BioSpace News Archive

Lantern Pharma Inc. (NASDAQ: LTRN), a clinical stage biopharmaceutical company using its proprietary artificial intelligence (“A.I.”) platform, RADR® , to transform oncology drug discovery and development, today announced financial results for the third quarter ended September 30, 2020.

Envista Holdings Corporation (NYSE: NVST) today announced results for the third quarter 2020.

ResMed Inc. (NYSE: RMD, ASX: RMD), a world-leading digital health company, today announced results for its quarter ended September 30, 2020.

Blue Water Vaccines, Inc., announced today that the Company is accelerating the development of a new vaccine candidate to combat the potential pandemic influenza strain, G4 EA H1N1, which was identified by scientists in China in the summer of 2020

Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it will report its third-quarter 2020 financial results after the close of the U.S. financial markets on Wednesday, November 4, 2020. The company hosted a conference call on October 13, 2020, in conjunction with reporting preliminary third-quarter net sales. A replay of that call is available on Flexion’s corporate website: https://ir.flexiont h erapeutics.com/events-and-pres

Rubius Therapeutics, Inc. (Nasdaq:RUBY), a clinical-stage biopharmaceutical company that is genetically engineering red blood cells to create an entirely new class of cellular medicines called Red Cell Therapeutics™, today announced plans to report third quarter 2020 financial results on Monday, November 9, 2020, before market open. The company will not be hosting a teleconference in conjunction with its financial results press release. A

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced financial results for the third quarter ended September 30, 2020.

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) today reported results for the quarter ended September 30, 2020.

How the Pacific Northwest accelerates and amplifies the growth and diversity of our life science and biotech clusters will be under the microscope at the Oregon Bio Digital 2020: Amplifying Diversity of Discovery, Access and Economics Conference.

Emmes announced that the Montgomery County Chamber of Commerce has selected Emmes as the recipient of its 2020 Corporate Achievement Award.